Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis.

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Abstract Text:

G Bertino,A M Ardiri,P Boemi,C M Bruno,M Valenti,M C Mazzarino,M Consolo,G S Calvagno,D Pulvirenti,S Neri,

AIM: Carbohydrate 19-9 antigen (CA 19-9) has been used in the diagnosis and follow-up of gastrointestinal tumors. However, a remarkable reduction of specificity has been described in subjects with chronic diseases. Elevated CA 19-9 serum levels have been described in non neoplastic liver diseases, such as hepatic cirrhosis, where they correlate with the fibrosis grade and the disease severity. The aim of the study is to evaluate CA 19-9 levels in chronic hepatitis patients (CH) and hepatic cirrhosis patients, Hepatitis C Virus (HCV)-correlated. Our goal was to establish whether elevated CA 19-9 levels can be considered a non casual event in chronic liver disease and whether a correlation can be found between CA 19-9 levels and the severity of the disease. METHODS: 116 patients have been recruited (76 m, 40 f, average 54 years); 56 patients were affected by CH and 60 by hepatic cirrhosis (Child A). All patients were HCV+, genotype 1b. Patients positive to CA 19-9 high levels were subjected to abdominal echography, EGDS, colonscopy, abdominal CT. RESULTS: Fifty two percent presented high levels of CA 19-9. None was affected by intestinal or pancreatic neoplasia, or colestatic icterus. CA 19-9 levels were elevated in 46% of patients with chronic hepatitis, and in 54% in patients with hepatic cirrhosis. Furthermore, CA 19-9 levels in hepatic cirrhosis compared to CA 19-9 levels in chronic hepatitis was statistically significant (P>0.007). CONCLUSION: Increased serum levels of CA 19-9 are frequent in chronic viral hepatitis; this often does not indicate a contemporary neoplastic disease and correlates in a statistically significant way (P>0.007) with the severity of the disease.

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Publishing Authors By Initials

G Bertino,AM Ardiri,P Boemi,CM Bruno,M Valenti,MC Mazzarino,M Consolo,GS Calvagno,D Pulvirenti,S Neri,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Minerva gastroenterologica e dietologica

VOLUME: 53

Page Numbers: 305-9

Journal Abbreviation:

ISSN: 1121-421X

DAY: 28

MONTH: Dec

YEAR: 2007

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9109791

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis.

AFFILIATION: Department of Internal Medicine and Systemic Diseases,St. Marta Hospital, University of Catania, Catania, Italy gaetanobertinounict@libero.it.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Minerva Gastroenterol Dietol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis Related Publications

• A 3-D CAD Tool for CT Colonography.
• A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.
• A monoclonal antibody prevents aggregation of the NBD1 domain of the cystic fibrosis transmembrane conductance regulator.
• A perceptually lossless, model-based, texture compression technique.
• A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy.
• Acute generalized exanthematous pustulosis induced by pentoxifylline.
• Antepartum death of one uniovular twin.
• Anti-chemokine therapy for inflammatory diseases.
• Antibody-based targeting of the tumor vasculature.
• Congenital nodular lesion of the anterior thorax in a child.
• Disgerminoma ovarii--treatment and prognosis.
• Fast-scale adaptive changes of directional tuning in fly tangential cells are explained by a static nonlinearity.
• Glucosinolates in Diplotaxis and Eruca leaves: Diversity, taxonomic relations and applied aspects.
• HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.
• Horner's syndrome in a patient with cervical sympathetic chain schwannoma.
• Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis.
• Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus (MPPH): report of a new case.
• Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
• Oral-facial-digital syndromes: review and diagnostic guidelines.
• Pedunculated nodule on an infant's face.
• Possible impacts of Hg and PAH contamination on benthic foraminiferal assemblages: an example from the Sicilian coast, central Mediterranean.
• Recurrent calcified cutaneous nodule of the perianal region.
• The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.
• Verrucous psoriasis in a patient with chronic C hepatitis treated with interferon.
• Wolf-Hirschhorn syndrome-associated chromosome changes are not mediated by olfactory receptor gene clusters nor by inversion polymorphism on 4p16.
• [Further studies on the photosensitizing properties of some phenothiazine derivatives. I. Promazine, chlorpromazine, promethazine.]
• [Future plans of the Department of Health and Social Welfare for the assistance to the states at the northern border of Mexico]
• [Hepatic iron, irondepletion and answer to the therapy with peg-Interferon and Ribavirin in chronic hepatitis C. Pilot study]
• [New technic with Viadril.]
• [Not Available.]